retatrutide ly3437943 glp-1 gip glucagon LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept The novel GIP, GLP‐1 and

Early clinical data suggests it may produce the most significant weight loss of the three, though it is newer to the research space and less widely available

Meetup: This social media platform offers thousands of opportunities for people seeking informal weight loss support, including fitness buddies

We dont just help you lose weightwe teach you how to maintain and build muscle so that you can live a strong, healthy life without relying on medications long-term

When in doubt, stop the product and contact your clinician

31 , 12371242 (2017) R

Despite being hailed as breakthrough medications for managing obesity, there are cases where the scale refuses to budge